Target intelligence / Profile preview

Apicoplast 50S ribosomal subunit

Molecular classification
Ribosome, Organelle ribosomal subunit, Other
01

Overview

The **Apicoplast 50S ribosomal subunit** is the large subunit of the ribosome found in the apicoplast, a non-photosynthetic plastid-like organelle present in apicomplexan parasites such as *Plasmodium* spp. (malaria pathogens) and *Toxoplasma gondii*. The apicoplast ribosome is prokaryote-like but highly reduced and divergent in protein composition compared to bacterial and chloroplast ribosomes, having lost or altered numerous subunits, and includes proteins encoded by both the parasite's nuclear and apicoplast genomes. It is essential for translation of a minimal set of apicoplast-encoded proteins, supporting crucial metabolic pathways such as fatty acid, isoprenoid, and heme synthesis that are indispensable for parasite survival and infectivity. Antibiotics that target prokaryotic ribosomes, such as tetracyclines and clindamycin, are effective against malaria and other apicomplexan infections largely through inhibition of this subunit, interfering with organellar protein synthesis—a unique vulnerability not present in humans. This makes the apicoplast 50S ribosomal subunit a validated therapeutic target for current antimicrobials and new antiparasitic drug development.

Other names
Apicoplast large ribosomal subunitApicoplast LSUApicoplast ribosomal large subunitPlasmodium apicoplast 50S ribosome
02

Mechanism of action

Inhibition of translation by binding to the ribosomal subunit, interfering with protein synthesis in the apicoplast (antibacterial-like mechanisms in a eukaryotic organelle)

03

Biological functions

Protein translationOrganelle biogenesisPeptide synthesisCellular metabolism (via support of apicoplast metabolic pathways)
04

Disease associations

Infection (notably malaria caused by *Plasmodium* spp. and other apicomplexan parasites)Other (antiparasitic drug targeting)
05

Safety considerations

Development of resistance (mutation in ribosomal proteins can confer drug resistance)Off-target toxicity is generally low, as these drugs exploit differences between parasite and host organelles
06

Interacting drugs

Tetracyclines (e.g., doxycycline)

2 more in the full profile.

07

Biomarkers

no established biomarkers for patient selection specific to this subunit; activity is inferred through organism susceptibility and apicoplast-targeting drug efficacy

Beyond the preview

Go deeper on Apicoplast 50S ribosomal subunit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apicoplast 50S ribosomal subunit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call